Scarica l'app Stockscreener
2.14
4.04%
-0.09
Dopo l'orario di chiusura:
2.14
Precedente Chiudi:
$2.23
Aprire:
$2.21
Volume 24 ore:
453.21K
Relative Volume:
0.86
Capitalizzazione di mercato:
$151.85M
Reddito:
-
Utile/perdita netta:
$-117.50M
Rapporto P/E:
-0.8917
EPS:
-2.4
Flusso di cassa netto:
$-114.31M
1 W Prestazione:
+7.00%
1M Prestazione:
+22.29%
6M Prestazione:
-14.06%
1 anno Prestazione:
-67.77%
Intervallo 1D:
$2.09
$2.23
Intervallo di 1 settimana:
$1.89
$2.25
Portata 52W:
$1.31
$7.24
Nkarta Inc Stock (NKTX) Company Profile
Nome
Nkarta Inc
Settore
Industria
Telefono
(925) 407-1049
Indirizzo
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Confronta NKTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.14 | 147.59M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-09 | Iniziato | Rodman & Renshaw | Buy |
| 2024-08-14 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-10 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-28 | Iniziato | Needham | Buy |
| 2022-07-18 | Iniziato | SVB Leerink | Outperform |
| 2022-03-11 | Iniziato | Raymond James | Outperform |
| 2022-03-08 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-06 | Iniziato | William Blair | Outperform |
| 2021-11-18 | Iniziato | SMBC Nikko | Outperform |
| 2021-07-16 | Iniziato | Oppenheimer | Outperform |
| 2020-08-04 | Iniziato | Cowen | Outperform |
| 2020-08-04 | Iniziato | Evercore ISI | Outperform |
| 2020-08-04 | Iniziato | Mizuho | Buy |
| 2020-08-04 | Iniziato | Stifel | Buy |
Mostra tutto
Nkarta Inc Borsa (NKTX) Ultime notizie
How high can Nkarta Inc. stock price go in 2025Free Technical Analysis Support - jammulinksnews.com
Nkarta Inc. Stock Analysis and ForecastHigh-performance investment picks - jammulinksnews.com
The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains - MedCity News
Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewswire
What analysts say about Nkarta Inc. stockSuperior portfolio returns - Autocar Professional
Is Nkarta Inc. a good long term investmentFree Technical Analysis Support - Autocar Professional
What drives Nkarta Inc. stock priceFree Real-Time Stock Data - jammulinksnews.com
How Nkarta Inc. stock performs during market volatilityFree Consultation - Newser
Nkarta: Holding Its Support Steady Ahead Of First Data Readouts In 2025 - Seeking Alpha
Why Nkarta Inc. stock attracts strong analyst attentionInsider Strategy Insight - Newser
What makes Nkarta Inc. stock price move sharplyFree Elite Traders Group - Newser
17,365 Shares in Nkarta, Inc. (NASDAQ:NKTX) Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Given Average Recommendation of “Buy” by Brokerages - Defense World
Nkarta (NASDAQ:NKTX) Stock Price Up 3% – Here’s What Happened - Defense World
Nkarta (NASDAQ:NKTX) Price Target Lowered to $14.00 at Mizuho - Defense World
Nkarta (NKTX) Maintains Outperform Rating as Mizuho Lowers Price Target | NKTX Stock News - GuruFocus
Two Sigma Investments LP Reduces Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta price target lowered to $14 from $16 at Mizuho - TipRanks
Nkarta (NKTX) Price Target Reduced by Mizuho | NKTX Stock News - GuruFocus
Nkarta, Inc. (NASDAQ:NKTX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Wellington Management Group LLP - Defense World
Bank of America Corp DE Grows Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Two Sigma Advisers LP Acquires New Stake in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta Names Shawn Rose as Chief Medical Officer - marketscreener.com
Nkarta Announces Leadership Change with New CMO - TipRanks
NKTX Appoints Shawn Rose as New Chief Medical Officer | NKTX Stock News - GuruFocus
Nkarta appoints Shawn Rose as CMO, head of R&D - TipRanks
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of - GlobeNewswire
Nkarta Taps Sotyktu, Stelara Developer as New CMO to Lead Autoimmune Disease Push - Stock Titan
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Nuveen Asset Management LLC - Defense World
ProShare Advisors LLC Invests $45,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Deutsche Bank AG Has $107,000 Stock Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Millennium Management LLC Boosts Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
BNP Paribas Financial Markets Invests $507,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta (NKTX) Moves to Buy: Rationale Behind the Upgrade - MSN
Nkarta Inc Azioni (NKTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):